Sumitomo Life Insurance CO Gilead Sciences, Inc. Transaction History

Sumitomo Life Insurance CO

$5.08 Billion
Q3 2024

A detailed history of Sumitomo Life Insurance CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sumitomo Life Insurance CO holds 17,822 shares of GILD stock, worth $1.65 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

17,822

Previous 17,705 0.66%

Holding current value

$1.65 Million

Previous $1.21 Million 22.98%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$66.59 - $83.99 $7,791 - $9,826	117 Added 0.66%	17,822 $1.49 Million
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $116,132 - $134,026	-1,839 Reduced 9.41%	17,705 $1.21 Million
Q1 2024 Apr 26, 2024	SELL	$71.58 - $87.29 $61,701 - $75,243	-862 Reduced 4.22%	19,544 $1.43 Million
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $76,054 - $86,247	-1,038 Reduced 4.84%	20,406 $1.65 Million
Q3 2023 Oct 23, 2023	SELL	$73.94 - $80.67 $20,629 - $22,506	-279 Reduced 1.28%	21,444 $1.61 Million
Q2 2023 Jul 20, 2023	SELL	$76.01 - $86.7 $140,466 - $160,221	-1,848 Reduced 7.84%	21,723 $1.67 Million
Q1 2023 Apr 27, 2023	SELL	$77.31 - $88.08 $13,606 - $15,502	-176 Reduced 0.74%	23,571 $1.96 Million
Q4 2022 Jan 17, 2023	SELL	$62.32 - $89.47 $20,627 - $29,614	-331 Reduced 1.37%	23,747 $2.04 Million
Q3 2022 Oct 31, 2022	SELL	$59.54 - $68.01 $170,403 - $194,644	-2,862 Reduced 10.62%	24,078 $1.49 Million
Q2 2022 Jul 22, 2022	BUY	$57.72 - $65.01 $26,435 - $29,774	458 Added 1.73%	26,940 $1.67 Million
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $38,343 - $48,047	-662 Reduced 2.44%	26,482 $1.57 Million
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $47,362 - $53,757	-730 Reduced 2.62%	27,144 $1.97 Million
Q3 2021 Oct 25, 2021	SELL	$67.69 - $73.03 $79,806 - $86,102	-1,179 Reduced 4.06%	27,874 $1.95 Million
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $312,208 - $341,132	-4,919 Reduced 14.48%	29,053 $2 Million
Q1 2021 Apr 27, 2021	SELL	$60.0 - $68.46 $98,880 - $112,822	-1,648 Reduced 4.63%	33,972 $2.2 Million
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $367,545 - $418,800	-6,488 Reduced 15.41%	35,620 $2.08 Million
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $126,746 - $159,361	-2,041 Reduced 4.62%	42,108 $2.66 Million
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $432,954 - $502,740	-5,985 Reduced 11.94%	44,149 $3.4 Million
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $31,502 - $40,350	503 Added 1.01%	50,134 $3.75 Million
Q4 2019 Jan 24, 2020	BUY	$61.62 - $67.78 $152,694 - $167,958	2,478 Added 5.26%	49,631 $3.23 Million
Q3 2019 Oct 24, 2019	SELL	$62.51 - $69.0 $377,997 - $417,243	-6,047 Reduced 11.37%	47,153 $2.99 Million
Q2 2019 Jul 26, 2019	BUY	$61.87 - $69.38 $116,872 - $131,058	1,889 Added 3.68%	53,200 $3.59 Million
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $242,803 - $272,004	-3,883 Reduced 7.04%	51,311 $3.34 Million
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $29,664 - $38,710	-490 Reduced 0.88%	55,194 $3.45 Million
Q3 2018 Oct 18, 2018	BUY	$71.28 - $78.92 $1.49 Million - $1.65 Million	20,944 Added 60.29%	55,684 $4.3 Million
Q2 2018 Jul 23, 2018	BUY	$64.88 - $75.68 $579,313 - $675,746	8,929 Added 34.59%	34,740 $2.46 Million
Q1 2018 Apr 27, 2018	SELL	$72.84 - $88.8 $82,819 - $100,965	-1,137 Reduced 4.22%	25,811 $1.95 Million
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $93,064 - $109,244	-1,308 Reduced 4.63%	26,948 $1.93 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $2.04 Million - $2.42 Million	28,256	28,256 $2.29 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Account

Sumitomo Life Insurance CO Gilead Sciences, Inc. Transaction History